Business
Cipla Ltd Press Release Jul 07 2023
Cipla Limited has informed the Exchange regarding a press release dated July 07, 2023, titled "Press Release ‐ Voluntary nationwide recall of six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to container defect by Cipla USA Inc., wholly owned step down subsidiary of the Company in USA".
About this update from Cipla Ltd
Cipla Limited has informed the Exchange regarding a press release dated July 07, 2023, titled "Press Release ‐ Voluntary nationwide recall of six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to container defect by Cipla USA Inc., wholly owned step down subsidiary of the Company in USA". View Attachment
More from Cipla Ltd
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda in the US
September 4, 2026
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in...
September 3, 2026